Occupational IgE sensitisation to phytase, a phosphatase derived from Aspergillus niger by Doekes, G. et al.
Occupational IgE sensitisation to phytase, a
phosphatase derived from Aspergillus niger
Gert Doekes, Nelleke Kamminga, Loes Helwegen, Dick Heederik
Abstract
Objective—Phytase is a phosphatase de-
rived from Aspergillus niger that en-
hances phosphate bioavailability in the
gut, and therefore has been increasingly
used as an animal feed additive since the
early 1990s. The aim of this study was to
assess whether work related respiratory
symptoms among workers in a so called
premix factory producing animal feed
additives, could be due to type I (mediated
by immunoglobulin E (IgE)) allergic sen-
sitisation to phytase.
Methods—Preparations of specific IgE
against phytase as used in the factory were
assessed by enzyme immunoassay (EIA)
in serum samples of 11 exposed workers
who regularly handled the enzyme, in 11
oYce and laboratory workers of the same
plant (non-exposed internal controls),
and in 19 laboratory animal workers as
external controls. The factory workers
also completed a questionnaire on com-
mon and work related respiratory symp-
toms.
Results—Depending on the cut oV level in
the EIA for IgE, and the preparation used
as coated allergen, antiphytase sensitisa-
tion was found in one to four of the 19
external controls, in one to five of the 11
internal controls, and in four to 10 of the
11 exposed workers. Strongest IgE reac-
tions were found in four exposed workers
who reported work related respiratory
symptoms, particularly wheezing, and in
one internal control who possibly had
become sensitised because the structure
of the factory building did not preclude
airborne exposure in the oYces and
corridors of the plant. Experiments with
inhibition EIA for IgE showed that (a)
phytase of another commercial source was
only partially cross reactive with phytase
as used in the premix factory, and (b)
phytase used as an animal feed additive
did not cross react with common mould
extracts, except for extracts from the spe-
cies of origin, Aspergillus niger. The
amount of IgE binding phytase in As-
pergillus niger was estimated to be be-
tween 0.1% and 1% of the extractable
mould proteins.
Conclusions—Phytase is a potentially im-
portant new occupational allergen causing
specific IgE immune responses among
exposed workers. Such IgE sensitisation
could probably be the cause of work
related asthmatic and other respiratory
symptoms if no eVective measures are
taken to prevent airborne occupational
exposure at sites where phytase is han-
dled, particularly during addition of en-
zyme preparations to animal feed.
(Occup Environ Med 1999;56:454–459)
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Advances in biotechnology during the past
decades have led to a remarkable increase in
the use of industrial enzymes, usually of micro-
bial origin. New enzymes have been introduced
to the feed and food industry, in household
products such as washing powders, and in vari-
ous other applications.1 Large scale production
of various new enzymes has become possible—
for example, by using genetically modified
strains of micro-organisms that can be easily
cultured under well controlled conditions.
Modification may involve duplication of genes
of interest, stimulation of gene expression by
modifying promotor regions in the DNA, or
incorporation into the genome enzyme coding
genes from other species that are more difficult
to culture. As many industrial enzymes are
known as type I allergens,2–5 the appearance of
these new enzymes on the market probably
implicates a simultaneous increase in exposure
to allergens, particularly in occupational popu-
lations involved in enzyme production and
delivery, and in industries where new enzyme
preparations are applied.
Phytase has been introduced in the early 90s
in the animal feed industry. Phytase is a phos-
phatase that releases phosphate from phospho-
rylated carbohydrate—particularly from the
indigestible phytate or phytinic acid—thus
enhancing the bioavailability of phosphate in
the gut of the animals,6–8 and reducing the need
for phosphate supplements in the feed. In this
way phosphate concentrations in the manure
and emissions of phosphate into the environ-
ment could be reduced considerably. The cur-
rently used phytase preparations, produced
from genetically modified strains of Aspergillus
niger (variety ficuum), are highly eVective, and
reduction of environmental emissions of phos-
phate by up to 30% or more has been
reported.8 9 It is thus not surprising that the use
of phytase as animal feed additive has found
wide acceptance and application.
Up to now, no allergic or other adverse reac-
tions to phytase have been published. In this
report we describe a serological and health
survey in a factory producing premixes—
specialised products containing vitamins, anti-
biotics, and other additives including phytase,
for use in animal feed production. The study
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was performed because some workers in this
factory reported serious work related respira-
tory health problems, particularly during and
after handling phytase preparations.
Materials and methods
POPULATION AND WORKPLACE
The study was inititated in the summer of 1995,
because of a case of presumably work related
respiratory illness in the premix factory. The
worker reported respiratory symptoms—
particularly wheezing and shortness of breath—
during addition of phytase to batches of animal
feed, one of his regular jobs. Two formulations
of phytase from the same supplier were used: a
solid powder and a concentrated phytase
solution (both with tradename Natuphos, Gist-
brocades, Delft, The Netherlands). During the
production process the enzyme powder was
added usually simply by hand, and the liquid
preparation was sprayed as an aerosol.
A small occupational health survey in the
factory was performed. From the 60 workers in
the production hall, 11 exposed workers—
those who regularly worked with phytase or at
a site close to where phytase was handled—
were asked to participate. As an internal
control group, 11 non-exposed subjects were
selected who worked in the oYce (n=8), the
laboratory (n=2), or the restaurant (n=1) of the
same factory. The survey included a standard-
ised respiratory health questionnaire as used in
previous studies,10 11 and serology to detect
specific IgE sensitisation to phytase, and to
assess the presence of atopy as a probable risk
factor or eVect modifier. In IgE serology we
also included an external control group of 19
serum samples from laboratory animal
workers.10 Of these 19 donors, 14 were atopic
as defined by a positive IgE serology on a panel
of four common allergens, or an enhanced
(>100 kU/l) total serum IgE.12
As workers in the animal feed industry have
an increased risk of respiratory disorders or
impaired lung function due to exposure to
organic dust, and particularly endotoxins,13 14
we also included a limited series of personal
and ambient air samples to assess dust and
endotoxin concentrations in this particular fac-
tory.
DUST AND ENDOTOXIN EXPOSURE
Personal full shift air sampling was performed
as described earlier, with Gilair samplers and
PAS-6 sampling heads equipped with glass
fibre filters (GF/A 2.5 cm; Whatman Inter-
national, UK); air was sampled at 2 l/min.15 In
total 24 samples were taken for gravimetric
assessment of dust concentrations. In 13 of
these samples endotoxin was also measured.
Filters were extracted with 5 ml pyrogen free
water with 0.05% Tween-20, and endotoxin
was measured in the extracts with a kinetic
limulus amoebocyte lysate (LAL) assay as
described earlier.16 Concentrations were ex-
pressed in endotoxin units (EU) / ml or / m3, in
which 1 10 EU corresponds to about 1 ng.
ENZYME AND ALLERGEN PREPARATIONS
Allergen preparations were obtained by extrac-
tion and dialysis of the solid and the liquid
phytase preparations used in the factory. Solid
phytase (2.5 g) was extracted for 2 days at 8°C
with 20 ml Coca’s buVer (0.94 M NaCl, 0.03
M NaHCO3, phenol 0.04 M, pH 7.2). After
centrifugation for 30 minutes at 24 500 g, the
supernatant was filtered through 0.45 µm
filters (Millipore, Molsheim, France), and then
extensively dialysed against phosphate buffered
saline (PBS). The liquid phytase preparation
(20 ml) was centrifuged, filtered and dialysed
against PBS, as described for the extract of the
solid product. Protein (BCA method, Pierce,
Rockford, IL, USA17) and carbohydrate18 were
measured as indicated. The powder extract
(labelled as phytase-Ns) contained 8 mg/ml
protein and 1 mg/ml carbohydrate, and the
processed liquid preparation (phytase-Nf) con-
tained 28 mg/ml protein and 4 mg/ml carbohy-
drate.
Commercially available lyophilised phytase
from Aspergillus niger was purchased from
Sigma Chemicals (St Louis, MO, USA;
product No P 9792); the 1 mg/ml solution in
PBS consisted of nearly 100% protein. This
preparation was labelled phytase-S.
Common allergen extracts from house dust
mites, grass, tree pollen, pets, and extracts of
fungal species Aspergillus niger, Aspergillus
oryzae, Aspergillus flavus, Aspergillus fumigatus,
and a mix of Penicillium species (Penicillium-4)
were obtained from ALK Benelux (Houten,
The Netherlands); á-amylase from Aspergillus
oryzae, used previously in studies on baker’s
allergy,11 came from NOVO Nordisk (Funga-
myl 1600S; NOVO Nordisk, Bagsvaerd, Den-
mark).
IgE SEROLOGY
Specific IgE antibodies reacting with phytase
allergen preparations, with mould extracts, or
with the common allergens were measured by
IgE enzyme immunoassay (EIA).12 The various
phytase preparations were coated to microwells
at 1:100 dilution in PBS, whereas the mould
extracts and other common allergens were
coated at 10–25 µg/ml. Diluted serum was
incubated in coated microwells in PBS with
0.05% Tween-20 and 0.2% gelatin, and bound
IgE was measured by sequential incubation
with mouse monoclonal antihuman IgE, aYn-
ity purified and biotinylated rabbit antimouse
Ig, and avidin peroxidase, all in PBS-Tween-
gelatin, after which o-phenylenediamine was
used as the peroxidase substrate. After addition
of 2N HCl, the optical density was read at 492
nm.
Total IgE was determined by a sandwich EIA
method.12
INHIBITION IgE ENZYME IMMUNOASSAY
Cross reactivity of allergen preparations was
tested by IgE inhibition EIA essentially as
described earlier.19 Aliquots of 50 µl test
samples were added to coated wells, after
which 50 µl of a diluted positive serum were
added to each well and mixed. The assay was
further continued as is standard procedure for
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the specific IgE EIA. The dilution of the posi-
tive serum samples was at least 1/5, and such
that the optical density at 492 nm (OD492) for
the no inhibitor controls—diluted serum mixed
with PBS-Tween-gelatin—was between 1.0
and 2.0.
Results
Dust and endotoxin exposures were similar to
those found in previous studies in the animal
feed industry.13 14 Although some protective
measures were taken against exposure to
dust—such as the use of a hood—there was
visible exposure in the breathing zone during
enzyme application. Geometric mean dust
concentrations for 8 hour averaged exposure in
various job titles or tasks ranged from 1.8 to
10.5 mg/m3; minimum and maximum values in
any of the measurements were 0.9 and 56.0
mg/m3. Endotoxin exposures assessed by area
sampling ranged from about 16 to >1000
EU/m3. Although the small numbers per
sampling site precluded definite conclusions,
endotoxin exposure seemed to be higher (up to
950 EU/m3) at sites where the enzyme phytase
was handled (not shown).
Figure 1 summarises the IgE reactions of
serum samples of workers and controls with
phytase-Nf. In the external control group one
weakly positive reaction and two borderline
reactions (OD between 0.05 and 0.10 above
the OD of the no serum control) were noted,
whereas of the 11 internal controls one reacted
strongly, and two showed a borderline IgE
reaction. By contrast, four of the 11 exposed
production workers reacted definitely and four
had a borderline reaction. The IgE reactions
with phytase-Nf in the exposed group were sig-
nificantly stronger than in either the external or
the internal controls (both p<0.005; Mann-
Whitney rank sum test). The assay with
phytase-Ns seemed to be more sensitive, but
the IgE reactions with the two preparations
were highly correlated, with an r2 for log trans-
formed OD values of >0.95 (not shown).
Thus, positive (OD > OD(blank)+0.100) and
borderline (0.05–0.10 above the OD(blank))
reactions on phytase-Ns were found in two and
two of the 19 external controls, in three and
two of the 11 internal controls, and in nine and
one of the 11 exposed workers, respectively.
Also the IgE reactivity with phytase-Ns was
significantly higher in exposed workers than in
external or internal controls (p<0.005; Mann-
Whitney rank sum test).
Six of the 11 exposed workers reported work
related respiratory symptoms: four reported
wheezing, chest tightness or shortness of
breath, one worker only cough, and one both
cough and asthmatic symptoms. As shown by
the diVerent symbols (fig 1), most of these
symptomatic workers were sensitised to
phytase, and the four workers with the highest
IgE titres all reported symptoms. By contrast,
only two workers in the non-exposed group
reported work related respiratory symptoms:
one worker who was (weakly) sensitised had
both asthmatic complaints and cough, and
another who was not phytase-sensitised re-
ported wheezing. The oYce worker with the
strong IgE antiphytase reaction reported respi-
ratory symptoms when at home after work, but
did not clearly identify the complaints as work
related, and was therefore labelled as having no
work related respiratory symptoms.
Three workers in the internal control group
and four in the exposed group were atopic, as
determined by EIA for total and allergen
specific IgE.12 There was a tendency to more
and stronger IgE antiphytase reactions among
the atopic people, but certainly no perfect
association (not shown). In fact, one worker in
the exposed group with moderate sensitisation
and complaints, and the oYce worker with the
strong antiphytase reaction, had no IgE to
common allergens or enhanced total IgE. The
other non-atopic workers all showed only weak
or no IgE reactions to phytase.
When tested in microwells coated with
phytase from a diVerent source (phytase-S),
only one serum sample showed a positive IgE
reaction, from one of the internal controls who
had a weak positive reaction towards
phytase-Ns and phytase-Nf, whereas all serum
samples with high IgE antiphytase-Ns and
antiphytase-Nf were negative on phytase-S.
Inhibition EIA experiments however showed
that phytase-S did contain the IgE-binding
components of phytase-Ns/Nf, but at much
lower concentrations (fig 2): complete inhibi-
tion could be achieved, but at about 20–50
times higher concentrations.
To investigate cross reactivity with common
mould allergens, all serum samples from the 11
internal controls and the 11 exposed workers
were also tested for IgE against extracts of three
Aspergillus species—Aspergillus fumigatus, As-
pergillus oryzae, and Aspergillus niger—and a
mix of four Penicillium species. No positive IgE
reactions were found with Aspergillus fumigatus,
Aspergillus oryzae, or Penicillium species,
whereas two serum samples had detectable IgE
against Aspergillus niger: the serum from the
oYce worker with strong phytase sensitisation,
and one of the two serum samples from
exposed workers with strong IgE antiphytase
sensitisation. These reactions with Aspergillus
niger were most likely due to cross reactivity, as
Figure 1 IgE antiphytase-Nf in external controls, in
internal controls, and in workers who regularly handled
phytase. Triangles and squares indicate serum samples from
workers with or without work related respiratory symptoms,
respectively. OD*(492) represents the OD492 in EIA wells
with test serum at 1/10, minus the mean OD492 in wells
with only diluent instead of serum. Horizontal lines indicate
the lower (0.05) and higher (0.10) threshold values for a
positive reaction.
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the Aspergillus niger preparation, but not the
other mould extracts, could inhibit the reac-
tions of these serum samples with coated
phytase-Ns and -Nf. The inhibition curves (fig
3 A, B) indicated that between 0.05% and 1%
of the crude Aspergillus niger extract would be
allergenic phytase.
Discussion
Phytase has been introduced as an animal feed
additive in the early 1990s, and has since then
found wide application; to our knowledge
without any report of adverse health eVects.
This report would thus be the first in which
occupational IgE sensitisation to phytase is
described, although recently antiphytase sensi-
tisation has also been found in enzyme produc-
tion in Germany (personal communication,
Baur et al, Bochum, Germany). The apparent
association with work related respiratory symp-
toms (fig 1) suggests that IgE sensitisation to
phytase was indeed also the cause of asthmatic
symptoms in the proband as well as in the other
workers. Obviously, confirmation of this con-
clusion would require further examinations of
exposed, sensitised, or symptomatic workers—
for example, by allergen specific provocation or
by peak flow monitoring before, during, and
after the work shift. Nevertheless, the high
prevalence of phytase specific sensitisation
indicates that phytase must be considered, like
other industrial enzymes, as an occupational
allergen, and should be handled as such in the
work environment. In fact, the supplier pro-
vides a printed warning that in principle
phytase may be a sensitiser, and within the
studied premix factory a hood was used at the
site of enzyme application. This, however,
seemed to be insuYcient to prevent sensitisa-
tion in this particular facility, and the present
findings thus clearly confirm that manual han-
dling of enzyme powders or spraying of enzyme
solutions at the workplace implicate a high risk
of occupational allergic sensitisation.
The positive reactions in the two control
groups might raise questions about the specifi-
city of the antiphytase IgE assay. However, the
strongest sensitisation was clearly found in
workers who were regularly involved in enzyme
application, and among laboratory animal
workers only weak or marginally positive reac-
tions were noted (fig 1). At first sight more sur-
prising was the strong reaction in one of the
oYce workers. A possible explanation may be
found in the structure of the building, in which
the oYce rooms were situated close to, and in
direct connection with the production hall
when the door was opened. Thus the risk of
exposure was certainly not zero for oYce
workers, especially not when leaving their room
and going through the factory.
Actual exposure measurements would be
required to verify that assumption, but an assay
for airborne phytase concentrations is not avail-
able as yet. We eluted soluble material from the
filters collected during dust sampling in the
present study and tried to measure phytase in
the extracts, with an IgG4 inhibition assay as in
our previous studies on exposure to wheat and
potato antigen,20 21 but no phytase anti-allergen
could be detected. This might have been due to
non-optimal extraction conditions and media, as
data from our own and other laboratories
indicate that for several allergens the addition of
a mild detergent such as Tween-20 markedly
increases the yield of eluted allergens.22 23 A
more likely explanation may be the relatively low
sensitivity of the IgG4 inhibition assay, which was
Figure 2 Allergenic cross reactivity of phytase
preparations, as shown by inhibition of the IgE reaction
with a coating of phytase-Nf. One of the serum samples
from exposed workers with a strong IgE antiphytase
reaction was tested in the EIA at 1/10.
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in the same order of magnitude as for IgE inhi-
bition (fig 3), and comparable with the sensitiv-
ity of the inhibition EIAs for potato or wheat
proteins (with a detection limit of about 10–25
ng/ml).20 21 Thus, detection limits for airborne
phytase would be at least 25–50 ng/m3, which in
fact is a high concentration for a single protein
allergen. For instance, we previously defined
high exposure to fungal á-amylase in bakeries as
job titles with a geometric mean exposure of
only 18 ng/m3, and a significantly enhanced risk
of occupational sensitisation and symptomatic
airway disease was found at this exposure, but
also at much lower mean á-amylase concentra-
tions of only 1-2 ng/m3.11 Thus a much more
sensitive assay would also be required for assess-
ment of exposure to airborne phytase, presum-
ably a sandwich immunoassay with monoclonal
or polyclonal antibodies from animals specifi-
cally immunised with purified phytase.
The prevalence of reported work related res-
piratory symptoms was remarkably high in this
small sample: especially wheezing and short-
ness of breath were reported by five of the 11
exposed workers, and by only two of the 11
oYce workers. Part of these symptoms might
have been due to exposure to dust or endotoxin
which seemed to be of the same order of mag-
nitude as concentrations at which respiratory
health eVects have been found in the animal
feed industry.13 14 On the other hand, among
the exposed workers the strongest IgE an-
tiphytase sensitisation was found among work-
ers with work related symptoms, and it
therefore seems highly likely that the IgE
immune response to phytase, like sensitisation
to other enzymes, can be an important
aetiological factor in the development of work
related respiratory disease.
Commercially available enzyme preparations
are usually not purified to complete homoge-
neity, and allergic sensitisation may thus often
be directed to either the active enzyme itself or
to one or more of the impurities. This may
explain why there was only partial cross
reactivity with Aspergillus niger phytase from
another source (fig 3). In preliminary blotting
experiments we found staining patterns that
were nearly identical for phytase-Ns and
phytase-Nf, but diVerent for phytase-S (not
shown). If these findings can be confirmed and
it could be shown that IgE sensitisation in some
people is mainly directed at impurities, produc-
tion of phytase preparations with similarly high
enzymatic activity, but with lower allergenic
potency should in principle be possible.
The lack of cross reactivity with phytase-S
may also be due to the use of a recombinant
Aspergillus niger strain for the production of
phytase-Ns and -Nf. It might be speculated
that the gene product of these genetically
modified microorganisms diVers in its fine
structure from the enzyme produced by the
native gene, such that a diVerent set of epitopes
is expressed on the recombinant phytase. This
also would require a much more detailed
immunochemical analysis of the epitopes
binding the antiphytase IgE antibodies. If so, it
might be speculated whether modern biotech-
nological techniques are capable of producing
recombinant enzymes, in which the active or
otherwise functionally important sites are fully
expressed but from which allergenic epitopes
have been removed.
The IgE inhibition assay with common
mould extracts (fig 3) indicated that allergenic
(or better: IgE binding) phytase would be
present in Aspergillus niger, but not in other
extracts. This implies that in principle sensiti-
sation to Aspergillus niger phytase may occur as
a consequence of exposure to Aspergillus niger
in the general (indoor home) environment.
The only two positive IgE antimould reactions
found in our population were, however, di-
rected to Aspergillus niger, and not to the other
common moulds, and these two serum samples
both reacted strongly with isolated phytase.
Therefore these IgE reactions against Aspergil-
lus niger were probably the consequence, and
not the cause of phytase sensitisation, which
thus really would be work related. We therefore
conclude that the present study has identified a
new example of occupational enzyme allergy,
and that strict control measures at the
workplace are required to keep airborne expo-
sure low and to ensure that the risk of
sensitisation and work related respiratory
disease will be minimal.
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